The Global Automated Whole-Breast Ultrasound Market is poised for significant growth, with market size expected to rise from USD 2.4 billion in 2023 to USD 10.7 billion by 2033, at a robust CAGR of 16.1% during the forecast period from 2024 to 2033. This growth can be attributed to several key factors. The increasing prevalence of breast cancer globally has heightened the demand for advanced diagnostic tools that can offer accurate and efficient screening. Automated whole-breast ultrasound systems, which are non-ionizing, provide a safer alternative to traditional mammography, particularly beneficial for women with dense breast tissue and those who undergo regular screening.

Automated Whole-Breast Ultrasound Market Share

Technological advancements, including the integration of artificial intelligence (AI), have played a crucial role in driving market growth. AI enhances the accuracy and efficiency of breast cancer detection by analyzing large volumes of imaging data more reliably than manual interpretation. Recent innovations, such as the introduction of the SOFIA 3D Breast Ultrasound System by Hitachi Ltd., underscore the continuous improvements in this field​.

Despite the promising growth prospects, the market faces challenges such as the high cost of advanced ultrasound systems, which can exceed USD 300,000 per unit, and the lack of trained professionals in certain regions. Additionally, inconsistent insurance coverage for automated breast ultrasounds adds financial burdens on patients and limits widespread adoption​.

Regionally, North America dominates the market due to its advanced healthcare infrastructure, significant investments in research and development, and high awareness of breast cancer screening. Europe and Asia-Pacific are also expected to witness substantial growth, driven by increasing healthcare expenditures and rising incidence of breast cancer.

Key Takeaways

  • By 2033, the global Automated Whole-Breast Ultrasound market is expected to reach USD 10.7 billion, growing at a CAGR of 16.1% from 2024.
  • In 2023, Automated Breast Ultrasound Systems (ABUS) led the market, capturing over 61% of the market share.
  • The Evaluation segment dominated the application segment in 2023, holding over 49% of the market share.
  • Hospitals were the leading end-use segment in 2023, accounting for over 52% of the market share.
  • North America held over 45.8% of the market share in 2023, valued at USD 1.1 billion.

Get Sample PDF Report: https://market.us/report/automated-whole-breast-ultrasound-market/request-sample/

Automated Whole-Breast Ultrasound Market Key Segments

Product Type

  • Automated Breast Ultrasound System
  • Automated Breast Volume Scanner

Application

  • Evaluation
  • Breast Cancer Screening
  • Breast Lesion Detection
  • Monitoring and Follow-up
  • Others

End-Use

  • Hospitals
  • DIagnostic Imaging Centres
  • Breast Health Clinics
  • Others

Key Regions

  • North America (The US, Canada, Mexico)
  • Western Europe (Germany, France, The UK, Spain, Italy, Portugal, Ireland, Austria, Switzerland, Benelux, Nordic, Rest of Western Europe)
  • Eastern Europe (Russia, Poland, The Czech Republic, Greece, Rest of Eastern Europe)
  • APAC (China, Japan, South Korea, India, Australia & New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Rest of APAC)
  • Latin America (Brazil, Colombia, Chile, Argentina, Costa Rica, Rest of Latin America)
  • Middle East & Africa (Algeria, Egypt, Israel, Kuwait, Nigeria, Saudi Arabia, South Africa, Turkey, United Arab Emirates, Rest of MEA)

Buy Directly: https://market.us/purchase-report/?report_id=83357

Key Players Analysis

Hitachi Ltd. is a key player in the automated whole-breast ultrasound sector with its SOFIA 3D breast ultrasound system. The SOFIA system is designed to address the challenges of dense breast tissue screening, offering a fast, comfortable, and efficient scanning process. The system provides scan times of 30 seconds per breast, allowing bilateral exams to be scheduled in 10-minute intervals. The SOFIA system’s design enhances patient comfort and privacy, significantly improving workflow efficiency in clinical settings​.

Siemens Healthcare Gmbh is notable for its Acuson series of ultrasound systems, which are integral to its offerings in automated whole-breast ultrasound. The Acuson systems, including the Acuson S2000 and Acuson ABVS (Automated Breast Volume Scanner), are designed to provide high-resolution 3D imaging. These systems enhance diagnostic accuracy and workflow efficiency, catering to the needs of modern healthcare facilities focused on early breast cancer detection and comprehensive breast health management.

Canon Medical Systems Corporation leverages its advanced imaging technologies in the automated whole-breast ultrasound market. The company’s systems, such as the Aplio i-series, are equipped with features that offer detailed imaging and streamlined workflows. These systems are designed to provide comprehensive breast imaging solutions, enhancing the detection and characterization of breast lesions. Canon’s focus on innovation and quality in imaging technology supports its strong position in this sector​.

General Electric Company, through GE Healthcare, has made significant advancements in automated whole-breast ultrasound technology. The Invenia ABUS (Automated Breast Ultrasound System) is a flagship product designed to improve cancer detection in women with dense breast tissue. The system provides consistent, high-quality imaging, and is known for increasing cancer detection rates by 57% when used alongside mammography. GE Healthcare’s commitment to innovation and patient care drives its prominence in this market.

Koninklijke Philips N.V. offers advanced solutions in automated whole-breast ultrasound through its EPIQ and Affiniti ultrasound systems. These systems are designed to deliver high-resolution images and integrate with Philips’ AI technologies to enhance diagnostic accuracy and efficiency. Philips focuses on providing patient-centered imaging solutions that support early detection and treatment planning for breast cancer, making it a significant player in the automated breast ultrasound market​.

Automated Whole-Breast Ultrasound Market Key Players:

  • Hitachi Ltd.
  • Siemens Healthcare Gmbh
  • Canon Medical Systems Corporation
  • General Electric Company
  • Koninklijke Philips N.V.
  • Hologic Inc.

Automated Whole-Breast Ultrasound Market Report Scope >> Market Value (2023): USD 2.4 Billion || Forecast Revenue (2033): USD 10.7 Billion || CAGR (2024-2033): 16.1% || Base Year Estimation: 2023 || Historic Period: 2019-2022 || Forecast Period: 2024-2033.

Inquire More about report: https://market.us/report/automated-whole-breast-ultrasound-market/#inquiry

About Market.US

Market.US is renowned for its comprehensive market research and analysis, providing customized and syndicated reports to a global clientele. Specializing in a variety of sectors, they offer strategic insights and detailed market forecasts, assisting businesses in making informed decisions. With a focus on innovation and accuracy, Market.US supports clients in over 126 countries, and maintains a strong repeat customer rate, underscoring their commitment to quality and client satisfaction. Their team excels in delivering exceptional research services, ensuring that no detail is overlooked in any target market.

Contact Details
Market.us (Powered By Prudour Pvt. Ltd.)
Contact No: +1 718 618 4351.
Email: [email protected]
Blog: https://medicalmarketreport.com/

View More Trending Reports

Brain Implants Market Will Reach USD 13.4 Billion By 2032 And Hit Around 9.2% CAGR

Medical Fiber Optics Market Hit USD 2,032 Million with A 6.4% CAGR By 2032

Aortic Aneurysm Market Projected To Reach USD 11 Billion By 2032

Medical Animation Market Projected Surge To USD 1,991.6 Million By 2032

Cancer Cachexia Market Projected To Reach USD 4024 Million With 4.8% CAGR By 2032